IL2 and renal cell carcinoma: We studied the in vivo activity of IL2-7NP2-TNFmut (directed to tumor cells) and IL2-F8-TNFmut (directed to the tumor neovasculature and stroma) in a xenograft model of renal cell carcinomas overexpressing human FAP on the cell surface [33,34].